These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30082227)

  • 1. Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR.
    Hamada M; Nishio N; Okuno Y; Suzuki S; Kawashima N; Muramatsu H; Tsubota S; Wilson MH; Morita D; Kataoka S; Ichikawa D; Murakami N; Taniguchi R; Suzuki K; Kojima D; Sekiya Y; Nishikawa E; Narita A; Hama A; Kojima S; Nakazawa Y; Takahashi Y
    EBioMedicine; 2018 Aug; 34():18-26. PubMed ID: 30082227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.
    Ramanayake S; Bilmon I; Bishop D; Dubosq MC; Blyth E; Clancy L; Gottlieb D; Micklethwaite K
    Cytotherapy; 2015 Sep; 17(9):1251-67. PubMed ID: 26212611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21.
    Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P
    Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells.
    Galvan DL; Nakazawa Y; Kaja A; Kettlun C; Cooper LJ; Rooney CM; Wilson MH
    J Immunother; 2009 Oct; 32(8):837-44. PubMed ID: 19752750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer.
    Field AC; Vink C; Gabriel R; Al-Subki R; Schmidt M; Goulden N; Stauss H; Thrasher A; Morris E; Qasim W
    PLoS One; 2013; 8(6):e68201. PubMed ID: 23840834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. piggyBac transposon system modification of primary human T cells.
    Saha S; Nakazawa Y; Huye LE; Doherty JE; Galvan DL; Rooney CM; Wilson MH
    J Vis Exp; 2012 Nov; (69):e4235. PubMed ID: 23149543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies.
    Tsukahara T; Iwase N; Kawakami K; Iwasaki M; Yamamoto C; Ohmine K; Uchibori R; Teruya T; Ido H; Saga Y; Urabe M; Mizukami H; Kume A; Nakamura M; Brentjens R; Ozawa K
    Gene Ther; 2015 Feb; 22(2):209-15. PubMed ID: 25427612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer.
    Jin C; Fotaki G; Ramachandran M; Nilsson B; Essand M; Yu D
    EMBO Mol Med; 2016 Jul; 8(7):702-11. PubMed ID: 27189167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.
    Bishop DC; Xu N; Tse B; O'Brien TA; Gottlieb DJ; Dolnikov A; Micklethwaite KP
    Mol Ther; 2018 Aug; 26(8):1883-1895. PubMed ID: 29861327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
    Manuri PV; Wilson MH; Maiti SN; Mi T; Singh H; Olivares S; Dawson MJ; Huls H; Lee DA; Rao PH; Kaminski JM; Nakazawa Y; Gottschalk S; Kebriaei P; Shpall EJ; Champlin RE; Cooper LJ
    Hum Gene Ther; 2010 Apr; 21(4):427-37. PubMed ID: 19905893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.
    Müller S; Bexte T; Gebel V; Kalensee F; Stolzenberg E; Hartmann J; Koehl U; Schambach A; Wels WS; Modlich U; Ullrich E
    Front Immunol; 2019; 10():3123. PubMed ID: 32117200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PiggyBac transposon-mediated gene transfer in human cells.
    Wilson MH; Coates CJ; George AL
    Mol Ther; 2007 Jan; 15(1):139-45. PubMed ID: 17164785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum pBac: An effective, high-capacity piggyBac-based gene integration vector system for unlocking gene therapy potential.
    Hua WK; Hsu JC; Chen YC; Chang PS; Wen KK; Wang PN; Yang WC; Shen CN; Yu YS; Chen YC; Cheng IC; Wu SC
    FASEB J; 2023 Sep; 37(9):e23108. PubMed ID: 37534940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.
    Huang X; Guo H; Tammana S; Jung YC; Mellgren E; Bassi P; Cao Q; Tu ZJ; Kim YC; Ekker SC; Wu X; Wang SM; Zhou X
    Mol Ther; 2010 Oct; 18(10):1803-13. PubMed ID: 20606646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
    Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
    J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.
    Hudecek M; Gogishvili T; Monjezi R; Wegner J; Shankar R; Kruesemann C; Miskey C; Ivics Z; Schmeer M; Schleef M
    Recent Results Cancer Res; 2016; 209():37-50. PubMed ID: 28101686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
    Kebriaei P; Singh H; Huls MH; Figliola MJ; Bassett R; Olivares S; Jena B; Dawson MJ; Kumaresan PR; Su S; Maiti S; Dai J; Moriarity B; Forget MA; Senyukov V; Orozco A; Liu T; McCarty J; Jackson RN; Moyes JS; Rondon G; Qazilbash M; Ciurea S; Alousi A; Nieto Y; Rezvani K; Marin D; Popat U; Hosing C; Shpall EJ; Kantarjian H; Keating M; Wierda W; Do KA; Largaespada DA; Lee DA; Hackett PB; Champlin RE; Cooper LJ
    J Clin Invest; 2016 Sep; 126(9):3363-76. PubMed ID: 27482888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in
    Morita D; Nishio N; Saito S; Tanaka M; Kawashima N; Okuno Y; Suzuki S; Matsuda K; Maeda Y; Wilson MH; Dotti G; Rooney CM; Takahashi Y; Nakazawa Y
    Mol Ther Methods Clin Dev; 2018 Mar; 8():131-140. PubMed ID: 29687032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene-modified T-cell therapy using chimeric antigen receptors for pediatric hematologic malignancies].
    Nakazawa Y
    Rinsho Ketsueki; 2016 Jun; 57(6):701-8. PubMed ID: 27384848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin landscapes of retroviral and transposon integration profiles.
    de Jong J; Akhtar W; Badhai J; Rust AG; Rad R; Hilkens J; Berns A; van Lohuizen M; Wessels LF; de Ridder J
    PLoS Genet; 2014 Apr; 10(4):e1004250. PubMed ID: 24721906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.